Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134903) titled 'investigator-initiated trial (IIT) to evaluate the safety and efficacy of zolpidem tablets in adult with insomnia disorder' on Oct. 22.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Peking University Sixth Hospital ( Institute of Mental Health )

Condition: Insomnia disorder

Intervention: Intervention group:Zolpidem tartrate tablets: take 1 tablet (10 mg) orally once before going to bed each night, for a total of 6 days.

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-10-23

Target Sample Size: Intervention group:8;Placebo group:4;

Countries of ...